English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Since the publication of this article, the authors have noticed an error in Figure 4a, specifically that the structures of the methyl-pomalidomide enantiomers were missing a carbonyl group. The error has now been rectified, and the correct article (with the correct figure 4) appears in this issue. The html and online pdf versions have also been rectified, and now carry the correct paper. The authors would like to apologise for any inconvenience this may have caused. Since the publication of this article, the authors have noticed an error contained within panel f of Figure 1. The correct figure is shown here. The authors would like to apologize for any inconvenience this may have caused.

Erratum: Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide